XZXuhua Zhang

Xuhua Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xuhua Zhang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Hai Xu

    State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao 266237, China

    3 shared publications
  • Guozhi Lv

    Key Laboratory of Ecological Metallurgy of Multi–Metal Intergrown Ores of Ministry of Education Northeastern University Shenyang China

    2 shared publications
  • Ling Li

    State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, China

    2 shared publications
  • Mengge Zhang

    State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, China

    2 shared publications
  • Mingyu Wang

    State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China

    2 shared publications
  • Ting-An Zhang

    Key Laboratory of Ecological Metallurgy of Multi–Metal Intergrown Ores of Ministry of Education Northeastern University Shenyang China

    2 shared publications

Latest Publications

  • Open Access

    A widespread single amino acid mutation in AcrA reduces tigecycline susceptibility in Klebsiella pneumoniae

    by Yingchao Xu, Wenjia Wang, Wenya Su, Mingyu Wang, Hai Xu, Xuhua Zhang, Ling Li

    Whole-genome sequencing of a clinical tigecycline non-susceptible Klebsiella pneumoniae strain reveals a novel T188A mutation in AcrA, raising awareness on its role in tigecycline resistance. Through structural analysis of AcrAB-TolC in Escherichia coli that is highly homologous to K. pneumoniae AcrAB-TolC , weaker hydrogen-bond interaction of the AcrA A188 with lipoyl domain than AcrA T188 was found, which may provide greater flexibility for substrate translocation. In order to explore the resistance mechanism of this mutation, wildtype and T188A mutant of acrA were cloned in pACYC184 and transformed into acrA deleted K. pneumoniae . Several experiments, including measurement of MICs for tigecycline, survival assays, and determination of intracellular tigecycline content, were performed and suggested that T188A mutation in AcrA led to increased tigecycline MIC, improved strain survival under tigecycline stress, and decreased intracellular tigecycline concentrations. Further examination of prevalence of this mutation showed its surprisingly wide presence, particularly in hypervirulent multidrug-resistant K. pneumoniae sequence types. These results support the role of T188A as a widespread AcrA mutation reducing tigecycline susceptibility in K. pneumoniae through increasing tigecycline efflux and improving tigecycline tolerance. IMPORTANCE: Tigecycline, a glycecycline antibiotic with broad-spectrum activity against almost all Gram-positive and Gram-negative bacteria, is a highly concerned “last-resort” antibiotic. In addition to plasmid-hosted mobile tet (X) conferring high-level resistance to tigecycline, there are many reports suggesting increased expression of AcrAB-TolC efflux pump leads to tigecycline non-susceptibility. However, the role of mutations in AcrAB-TolC on tigecycline resistance has not been identified. This study reports a novel T188A mutation of the AcrA subunit of AcrAB-TolC complex in a clinical tigecycline-resistant Klebsiella pneumoniae strain and reveals the role of AcrA mutation on tigecycline resistance in K. pneumoniae . High prevalence of A188 type AcrA in hypervirulent multidrug-resistant K. pneumoniae indicates that mutations of the AcrAB-TolC complex may play a larger role in determining bacterial pathogenesis and antibiotic susceptibility than previously expected.


  • Open Access

    Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial

    by Xiaofeng Tang, Biaolong Deng, Aiping Zang, Xiaowen He, Ye Zhou, Daimeng Wang, Dan Li, Xueyu Dai, Jieqiong Chen, Xuhua Zhang, et al.

    Background: Aging is usually accompanied by functional declines of the immune system, especially in T-cell responses. However, little is known about ways to alleviate this.Methods: Here, 37 middle-aged healthy participants were recruited, among which 32 were intravenously administrated with expanded NK cells and 5 with normal saline. Then, we monitored changes of peripheral senescent and exhausted T cells within 4 weeks after infusion by flow cytometry, as well as serum levels of senescence-associated secretory phenotype (SASP)-related factors. In vitro co-culture assays were performed to study NK-mediated cytotoxic activity against senescent or exhausted T cells. Functional and phenotypic alteration of NK cells before and after expansion was finally characterized.Results: After NK cell infusion, senescent CD28-, CD57+, CD28-CD57+, and CD28-KLRG1+ CD4+ and CD8+ T-cell populations decreased significantly, so did PD-1+ and TIM-3+ T cells. These changes were continuously observed for 4 weeks. Nevertheless, no significant changes were observed in the normal saline group. Moreover, SASP-related factors including IL-6, IL-8, IL-1α, IL-17, MIP-1α, MIP-1β, and MMP1 were significantly decreased after NK cell infusion. Further co-culture assays showed that expanded NK cells specifically and dramatically eliminated senescent CD4+ T cells other than CD28+CD4+ T cells. They also showed improved cytotoxic activity, with different expression patterns of activating and inhibitory receptors including NKG2C, NKG2A, KLRG1, LAG3, CD57, and TIM3.Conclusion: Our findings imply that T-cell senescence and exhaustion is a reversible process in healthy individuals, and autologous NK cell administration can be introduced to alleviate the aging.Clinical Trial Registration: ClinicalTrials.gov, ChiCTR-OOh-17011878.


  • Open Access

    New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain

    by Weiwei Li, Jiamin Hu, Ling Li, Mengge Zhang, Qingyu Cui, Yanan Ma, Hainan Su, Xuhua Zhang, Hai Xu, Mingyu Wang

    Daptomycin (DAP), a last-resort antibiotic for treating Gram-positive bacterial infection, has been widely used in the treatment of vancomycin-resistant enterococci (VRE). Resistance to both daptomycin and vancomycin leads to difficulties in controlling infections of enterococci. A clinical multidrug-resistant Enterococcus faecium EF332 strain that shows resistance to both daptomycin and vancomycin was identified, for which resistance mechanisms were investigated in this work. Whole-genome sequencing and comparative genomic analysis were performed by third-generation PacBio sequencing, showing that E. faecium EF332 contains four plasmids, including a new multidrug-resistant pEF332-2 plasmid. Two vancomycin resistance-conferring gene clusters vanA and vanM were found on this plasmid, making it the second reported vancomycin-resistant plasmid containing both clusters. New mutations in chromosomal genes cls and gdpD that, respectively, encode cardiolipin synthase and glycerophosphoryl diester phosphodiesterase were identified. Their potential roles in leading to daptomycin resistance were further investigated. Through molecular cloning and phenotypic screening, two-dimensional thin-layer chromatography, fluorescence surface charge test, and analysis of cardiolipin distribution patterns, we found that mutations in cls decrease surface negative charges of the cell membrane (CM) and led to redistribution of lipids of CM. Both events contribute to the DAP resistance of E. faecium EF332. Mutation in gdpD leads to changes in CM phospholipid compositions, but cannot confer DAP resistance. Neither mutation could result in changes in cellular septa. Therefore, we conclude that the daptomycin resistance of E. faecium EF332 is conferred by new cls mutations. This work reports the genetic basis for vancomycin and daptomycin resistance of a multidrug-resistant E. faecium strain, with the finding of new mutations of cls that leads to daptomycin resistance.


  • Open Access

    A Clinical Extensively-Drug Resistant (XDR) Escherichia coli and Role of Its β-Lactamase Genes

    by Mingyu Wang, Wenjia Wang, Yu Niu, Ting Liu, Ling Li, Mengge Zhang, Ziyun Li, Wenya Su, Fangyue Liu, Xuhua Zhang, et al.

    An extensively-drug resistant (XDR) Escherichia coli W60 was isolated from the urine sample of a patient. The genetic basis for its XDR phenotype was investigated, particularly the basis for its resistance toward β-lactam/BLI (β-Lactamase Inhibitor) combinations. Following determination of the XDR phenotype, third generation genomic sequencing was performed to identify genetic structures in E. coli W60. Further cloning analysis was performed to identify determinants of β-lactam/BLI combination resistance. It was found that E. coli W60 is resistant to nearly all of the tested antibiotics including all commonly used β-lactam/BLI combinations. Analysis of the genomic structures in E. coli W60 showed two novel transferable plasmids are responsible for the resistance phenotypes. Further genetic analysis showed blaNDM–5 leads to high resistance to β-lactam/BLI combinations, which was enhanced by co-expressing bleMBL. pECW602 harbors a truncated blaTEM that is not functional due to the loss of the N-terminal signal peptide coding region. Research performed in this work leads to several significant conclusions: the XDR phenotype of E. coli W60 can be attributed to the presence of transferable multidrug resistance plasmids; NDM-5 confers high resistance to β-lactam/BLI combinations; co-expression of bleMBL enhances resistance caused by NDM-5; the signal peptides of TEM type β-lactamases are essential for their secretion and function. Findings of this work show the danger of transferable multidrug resistance plasmids and metallo-β-lactamases, both of which should be given more attention in the analysis and treatment of multidrug resistant pathogens.


  • Study on effective extraction of Al and Fe from high-iron bauxite through “calcification-carbonization” method

    by Zhang Weiguang, Zhang Ting’an, Lv Guozhi, Zhang Xuhua, Zhu Xiaofeng, Wang Yanxiu, Wang Long

  • Effects of Roasting Pretreatment in Intense Magnetic Field on Digestion Performance of High Iron Bauxite

    by Lv Guozhi, Zhang Ting’an, Zhang Xuhua, Liu Yan, Dou Zhihe, He Jicheng

  • Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats

    by Yang Zhang, Yong-Hui Wang, Xu-Hua Zhang, Hong-You Ge, Lars Arendt-Nielsen, Jian-Min Shao, Shou-Wei Yue

    The aim of the study was to identify the differential protein expressions related to neuropathic pain and neuroprotection in the dorsal root ganglion (DRG) following chronic compression of DRG (CCD) in rats. We conducted a proteomics study of L4 and L5 DRG after CCD for 28 days. A total of 98 protein spots were detected with significant changes in their expression levels after CCD and 15 protein spots were identified by the matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis. Of these proteins, annexin A2, protein kinase C epsilon (PKCε), glyceraldehyde-3-phosphate dehydrogenases (GAPDH), and heat shock protein 70 (HSP70) were up-regulated significantly compared with the normal control. These four proteins and p11, which was annexin A2 light chain, were further examined by Western blotting. The results of Western blotting and the proteomic analysis showed consistent data. Moreover, real-time quantitative RT–PCR experiments indicated that CCD-induced increase in protein levels was associated with an up-regulation of annexin A2 and PKCε gene expression. In conclusion, this study highlights the molecular process in DRG underlying neuropathic pain. CCD is associated with the up-regulation of annexin A2 and PKCε and their related genes. The up-regulation of GAPDH and HSP70 suggests that there exist concurrent processes of nervous injury and neuroprotection in the course of neuropathic pain.


  • Open Access

    Proteomics Analysis of the Proliferative Effect of Low-Dose Ouabain on Human Endothelial Cells

    by Jie Qiu, Hai-Qing Gao, Rui-Hai Zhou, Ying Liang, Xu-Hua Zhang, Xu-Ping Wang, Bei-An You, Mei Cheng

    Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies